Archives
-
Toremifene vs Tamoxifen in Advanced Breast Cancer
2026-09-04
This Cochrane review directly compares toremifene and tamoxifen for advanced breast cancer, synthesizing evidence on tumor response, disease control, survival, and adverse effects. Its central conclusion is that the two selective estrogen receptor modulators show broadly comparable clinical performance, while differences in patient context and toxicity remain important for treatment selection and future research.
-
Triacetin: From Lipid Chemistry to Translational Strategy
2026-09-04
Triacetin is more than a formulation excipient: its hydrolyzable lipid chemistry links acetate and glycerol metabolism with epigenetic, apoptotic, and cell-cycle biology. This thought-leadership guide helps translational researchers evaluate its opportunities, boundaries, and experimental maturity.
-
Sulfo-NHS-SS-Biotin: Practical Labeling Guide
2026-09-03
Sulfo-NHS-SS-Biotin provides water-compatible, amine-selective biotinylation with a cleavable disulfide spacer for affinity capture, detection, and label removal. It is appropriate for primary-amine-containing proteins and intact-cell surface workflows, but it should not be treated as a stable premixed solution or used without validation in samples containing competing amines or reduction-sensitive disulfides.
-
D-Luciferin Potassium Salt for Preclinical BLI
2026-09-03
D-Luciferin potassium salt provides a water-soluble route to longitudinal firefly luciferase imaging, from tumor cell tracking to reporter and ATP assays. This workflow-focused guide shows how to prepare, standardize, and troubleshoot substrate delivery when studying EGFR-mutant brain metastasis models and treatment response.
-
Amyloid β-Peptide (1-42) (human) Assays
2026-09-02
A practical, scenario-based guide to using Amyloid β-Peptide (1-42) (human), SKU B6057, in neuronal viability, cytotoxicity, and ion-channel studies. It connects documented peptide properties with assay design, handling, interpretation, and vendor-selection decisions for more defensible Alzheimer's disease research.
-
Cap 1 Firefly Luciferase mRNA for Translational Insight
2026-09-02
A thought-leadership guide to using Cap 1 firefly luciferase mRNA as a mechanistically informed benchmark for delivery, intracellular release, translation, and in vivo imaging studies.
-
Fluorescein Tyramide for Neural Signal Amplification
2026-09-01
Fluorescein Tyramide converts weak HRP-dependent targets into spatially confined green fluorescence for demanding neural IHC, ISH, and fixed-cell flow workflows. This guide connects oxytocin-circuit findings in early-life-adversity research with practical assay design, optimization controls, and troubleshooting decisions.
-
Sulfur Supply Delays Soybean Nodule Senescence
2026-09-01
The reference study identifies sulfur delivery to the symbiosome as a regulatory control point in soybean nodule longevity. By connecting SULTR2;1 and SULTR3;5 transport activity with glutathione-dependent reactive nitrogen species scavenging, the work shows how sulfur availability can preserve nitrogen fixation under high-nitrogen stress.
-
Azithromycin and Roxithromycin as Senolytics
2026-08-31
Ozsvari and colleagues used a DNA-damage-induced human fibroblast model to screen approved antibiotics for selective activity against senescent cells. The study identified azithromycin and roxithromycin as senolytic candidates, while closely related erythromycin lacked comparable activity, highlighting the value of structure-sensitive drug repurposing and orthogonal senescent cell detection.
-
HRP Goat Anti-Rabbit IgG (H+L) Antibody
2026-08-31
HRP Goat Anti-Rabbit IgG (H+L) Antibody, SKU K1223, provides enzyme-linked detection of rabbit IgG for Western blotting, ELISA, IHC, and immunocytochemistry. It is intended for research workflows only, not diagnostic or medical use, and should be validated with the selected primary antibody, sample matrix, substrate, and imaging system.
-
WY-14643: Practical PPARα Assay Workflows
2026-08-30
WY-14643 (Pirinixic Acid) provides a practical pathway-activation tool for studying lipid metabolism, endothelial inflammation, and insulin sensitivity. This guide connects receptor-focused assays with integrated omics, exposure design, and troubleshooting strategies for more defensible metabolic disorder research.
-
NLRP10 and Epidermal Homeostasis in Atopic Dermatitis
2026-08-29
The reference study establishes NLRP10 as a functional regulator of epidermal homeostasis rather than only an atopic dermatitis susceptibility locus. Using human skin evidence and an air-lift skin-equivalent model, it links NLRP10 to keratinocyte survival through caspase-8 control and to differentiation and barrier formation through p63 stabilization.
-
Biotin-XX Tyramide Reagent for Synaptic Mapping
2026-08-28
Biotin-XX Tyramide Reagent combines HRP-driven signal amplification with membrane-impermeant surface labeling, making it useful for detecting scarce proteins at neuronal membranes and tissue interfaces. This guide translates activity-dependent LGI1 biology into practical IHC, ISH, and proximity-labeling workflows while emphasizing controls, timing, and troubleshooting.
-
Biotin-XX Tyramide Reagent for Spatial Biology
2026-08-28
Biotin-XX Tyramide Reagent converts HRP localization into a highly sensitive, membrane-restricted spatial readout for IHC and ISH. This article explains how biotin-LC-LC-tyramide can clarify cell-surface signaling and migration biology without confusing amplification with mechanistic proof.
-
FLNa–NF-κB Control of Hepatitis E Virus Replication
2026-08-27
The reference study identifies filamin A (FLNa) as a host cytoskeletal factor that connects HEV infection with NF-κB signaling, apoptosis, and inflammatory responses. Its evidence suggests that HEV-driven suppression of FLNa blocks IκB degradation and NF-κB nuclear translocation, creating conditions that favor viral replication and virion release.